NHS National Generic Pharmaceuticals Wave 14c

Concepts

• pharmaceutical products
• runcorn
• nhs national generic pharmaceuticals wave
• nhs
• national
• 14c
• generic
• pharmaceuticals
• wave
• hospital only products

Location

Description

Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN): 01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026 (24 months) Hospital Only Products (Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025 (8 months) DCE & DSW: 01/06/2024 to 30/09/2025 (16 months)

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk Document No. 05a (v) Product Listing and Usage - Hospital Only (Housekeeping) Products (DCE, DSW, DNW & DLN) CM_PHG_22_5672_03 Document No. 05a (v) Product Listing and Usage - Hospital Only (Housekeeping) Products (DCE, DSW, DNW & DLN) CM_PHG_22_5672_03.xlsx Document No. 01 - Invitation to offer covering letter Document No. 01 - Invitation to offer covering letter.docx Document No. 00 - Read Me First Document Document No. 00 - Read Me First Document.docx Document No. 05a (i) - Product Listing and Usage - Oral (plus non parenteral) Products (CESW, LSNE & NWLN) CM_PHG_22_5672_01 Document No. 05a (i) - Product Listing and Usage - Oral (plus non parenteral) Products (CESW, LSNE & NWLN) CM_PHG_22_5672_01.xlsx Document No. 05a (ii) (iv) and (vi) CM_PHG_22_5668 SELECTT Application Document No. 05a (ii) (iv) and (vi) CM_PHG_22_5668 SELECTT Application.docx Document No. 05a (iii) - Product Listing and Usage - Hospital Only (DLS & DNE) CM_PHG_22_5672_02 Document No. 05a (iii) - Product Listing and Usage - Hospital Only (DLS & DNE) CM_PHG_22_5672_02.xlsx Document No. 02 - Terms of offer Document No. 02 - Terms of offer.doc Document No. 03 - Framework Agreement and Terms and Conditions Document No. 03 - Framework Agreement and Terms and Conditions.pdf Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements.docx Document No. 04a - Quality Assurance Process Document No. 04a - Quality Assurance Process.doc Document No. 05b - Selectt offer schedule instructions Document No. 05b - Selectt offer schedule instructions.docx Document No. 06 - Form of offer Document No. 06 - Form of offer.doc Document No. 09 - Stability Data Requirements Document No. 09 - Stability Data Requirements.xlsx Document No. 07a - Quality control technical sheet Document No. 07a - Quality control technical sheet.doc Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023) Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023).pdf Document No. 08 - Confidential information schedule Document No. 08 - Confidential information schedule.xls